Prev Arrow Stocks

Humana Inc. ($HUM) Stock Forecast: Down 6.7% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Humana Inc.?

Humana Inc. (HUM) is a health insurance company offering various health and wellness products and services in the United States.

Why is Humana Inc. going down?

HUM stock is down 6.7% on Oct 10, 2025 13:40

  • The bearish movement in Humana's stock today could be attributed to an ongoing investigation, causing uncertainty among investors.
  • The news of a competitor expanding its initiative to reduce hospital readmissions may have negatively impacted Humana's stock, signaling increased competition in the healthcare sector.
  • Despite a recent jump in Humana's share price, the lack of promising trends in earnings estimate revisions may have contributed to today's bearish movement.
  • Investors might be reacting to the overall sentiment in the healthcare industry, leading to a sell-off in Humana's stock amidst uncertainties about the company's future prospects.

HUM Price Chart

HUM Technical Analysis

HUM News

CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions

CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.

https://www.zacks.com/stock/news/2765408/cvs-healths-aetna-advances-initiative-to-curb-hospital-readmissions

0 Missing News Article Image CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions

HUMANA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Humana ( NYSE:HUM )

Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana ( HUM ) To Contact Him Directly To Discuss Their Options

https://www.benzinga.com/pressreleases/25/10/g48110583/humana-investigation-alert-bragar-eagel-squire-p-c-continues-investigation-into-humana-inc-on-beha

1 News Article Image HUMANA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Humana  ( NYSE:HUM )

Humana ( HUM ) Moves 4.0% Higher: Will This Strength Last?

Humana (HUM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

https://www.zacks.com/stock/news/2761803/humana-hum-moves-40-higher-will-this-strength-last

2 Missing News Article Image Humana  ( HUM )  Moves 4.0% Higher: Will This Strength Last?

Humana Inc. Price History

02.09.2025 - HUM Stock was down 0.2%

  • Humana's stock experienced a bearish movement today, possibly due to:
  • Pressure from high benefit ratios and costs impacting the company's profitability.
  • Investor concerns raised by an investigation initiated by Bragar Eagel & Squire, P.C., leading to a loss in investor confidence.
  • Despite benefiting from rising premiums and Medicare growth, these positive factors might have been overshadowed by the negative aspects, contributing to the bearish trend.
  • The comparison with Akero Therapeutics, Inc. might have also influenced investor sentiment, especially if Akero Therapeutics has been outperforming Humana in the sector, leading to a shift in investment focus away from Humana.

17.03.2025 - HUM Stock was down 7.3%

  • Humana's stock experienced a bearish movement today, likely influenced by the negative earnings report from UnitedHealth, a major competitor in the health insurance industry.
  • The disappointing earnings results from UnitedHealth may have raised concerns among investors about the overall health insurance sector, leading to a sell-off in stocks like Humana.
  • This market reaction highlights the interconnectedness of companies within the same industry, where one company's performance can impact the sentiment and stock prices of its competitors.
  • Investors will be closely monitoring future earnings reports and industry developments to assess the potential impact on Humana's stock performance in the coming days.

10.09.2025 - HUM Stock was down 6.7%

  • The bearish movement in Humana's stock today could be attributed to an ongoing investigation, causing uncertainty among investors.
  • The news of a competitor expanding its initiative to reduce hospital readmissions may have negatively impacted Humana's stock, signaling increased competition in the healthcare sector.
  • Despite a recent jump in Humana's share price, the lack of promising trends in earnings estimate revisions may have contributed to today's bearish movement.
  • Investors might be reacting to the overall sentiment in the healthcare industry, leading to a sell-off in Humana's stock amidst uncertainties about the company's future prospects.

13.04.2025 - HUM Stock was down 6.2%

  • Indications of optimistic trading positions from wealthy investors may have boosted confidence in Humana's future.
  • Legal inquiries by law firms potentially regarding claims against Humana could have prompted worries about legal risks and compliance challenges, resulting in a decline in the stock value.
  • The interplay between positive options activity and legal scrutiny probably generated market unpredictability and unease, influencing the downward trend in Humana's stock value.

02.08.2025 - HUM Stock was up 3.0%

  • Humana's strong bullish movement today can be attributed to the company's expansion of musculoskeletal care access through new value-based partnerships. This move not only enhances the company's service offerings but also demonstrates its commitment to improving healthcare outcomes for its members.
  • The positive investor sentiment towards Humana may also be fueled by the company's solid financial performance, as indicated by its 19.2% increase since the last earnings report. This growth trajectory suggests that Humana is effectively executing its strategic initiatives and delivering value to its shareholders.
  • In contrast, the struggles faced by Centene may have further boosted investor confidence in Humana. The comparison with Centene, which has seen a significant decline in its share price, likely underscored Humana's relative strength and stability in the healthcare sector.

19.08.2025 - HUM Stock was down 5.3%

  • The bearish movement in Humana's stock today could be attributed to an investigation initiated by the former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., into the officers and directors of the company. This news might have raised concerns among investors about potential legal issues or regulatory challenges that could impact Humana's operations and financial performance.
  • The uncertainty surrounding the investigation could have led to a lack of confidence in the company's leadership and governance practices, prompting investors to sell off their positions in Humana's stock.
  • As investors typically react negatively to legal investigations and regulatory scrutiny, the bearish trend in Humana's stock today reflects the market's cautious sentiment towards the company's current situation and the potential implications of the ongoing probe.

17.05.2025 - HUM Stock was up 5.0%

  • UnitedHealth's strong bullish movement today can be attributed to the company's medical membership surpassing 50 million, indicating a growing customer base and revenue potential.
  • Concerns about high Medicare costs may have initially dampened investor sentiment, but the overall positive trend in the healthcare sector likely overshadowed these worries.
  • The company's ability to maintain this momentum will depend on its strategies to manage and control costs, while continuing to attract and retain members in a competitive market.
  • Investors are likely optimistic about UnitedHealth's growth prospects, despite the challenges posed by healthcare costs, driving the stock's bullish movement today.

06.07.2025 - HUM Stock was up 5.4%

  • There is an ongoing investigation on behalf of long-term stockholders regarding Humana Inc., which could indicate potential legal issues or concerns within the company.
  • Investors who have faced losses with Humana are being advised to consult a litigation attorney, hinting at possible ongoing challenges or uncertainties affecting the stock.
  • The positive movement in Humana's stock today could be linked to favorable earnings reports, new business ventures, or market speculation on future growth prospects.
  • Despite the investigation and potential losses, investors seem optimistic about Humana's resilience in navigating legal issues and providing value, leading to increased buying activity and a higher stock price.

17.06.2025 - HUM Stock was down 0.3%

  • Analysis indicates that Humana's shares are oversold and close to a support level, suggesting a potential turnaround with a upward movement soon.
  • Although the stock consolidated on Wednesday, there is hope for a shift from a bearish trend to a bullish rally.
  • The downward movement might be due to general market sentiment or industry-specific updates affecting Humana's stock value.
  • Traders are advised to monitor any further developments closely to evaluate the possibility of a positive reversal in Humana's stock.

01.09.2025 - HUM Stock was down 4.6%

  • The bearish movement in Humana's stock today could be attributed to the unusual options activity indicating that high-rolling investors have taken a bearish stance on the company.
  • The investigation by Bragar Eagel & Squire, P.C. on behalf of long-term stockholders might have raised concerns among investors, leading to a sell-off in the stock.
  • The comparison with Akero Therapeutics and other medical peers in the sector may have highlighted relative underperformance, further dampening investor sentiment towards Humana.
  • Overall, the combination of negative news flow and bearish market sentiment from high-profile investors likely contributed to the significant downward movement in Humana's stock price today.

30.06.2025 - HUM Stock was up 5.4%

  • Humana (HUM) reported Q2 earnings that slightly lagged estimates, but revenue exceeded expectations, showing overall positive performance.
  • The strength in insurance premiums and Medicare helped offset rising costs and membership declines, indicating resilience in the company's core business.
  • Analysts expect Humana to beat earnings estimates, suggesting positive sentiment and potential for the stock to move higher in the near future.
  • The combination of positive revenue surprises and expectations of beating earnings estimates likely contributed to the strong bullish movement in Humana's stock today.

30.06.2025 - HUM Stock was up 7.9%

  • Humana exceeded Q2 adjusted EPS expectations, showcasing resilience and strong financial performance.
  • The company's upward revision of its 2025 revenue forecast to at least $128 billion indicates robust growth prospects and strategic planning.
  • Despite some concerns about earnings lagging estimates and rising costs, the overall market sentiment towards Humana seems positive, driven by its solid performance and future growth potential.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.